glutathione synthetase deficiency schizophrenia
glutathione synthetase deficiency schizophrenia in the early postnatal developmental period as a neurodevelopmental animal model of | Pharmacological Reports Glutamate in schizophrenia: Neurodevelopmental perspectives
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development ScienceDirect Altered serum glutathione disulfide levels in acute relapsed schizophrenia are associated with clinical symptoms and response to electroconvulsive therapy BMC Psychiatry Springer Nature Link Molecular Medicine Reports Cystine Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
USD28.49
USD58.49
Pay in 4 interest-free payments of $7.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
